MSAC consultations

The Medical Services Advisory Committee (MSAC) meets 3 times a year to assess applications of new medical services. For most items being considered there are 2 consultation periods: prior to the PICO Advisory Sub-Committee (PASC) meeting, and prior to the MSAC meeting.

Learn more about the MSAC and the Medicare Benefits Schedule (MBS).

Open MSAC consultations

Listed below and via the ‘show more’ button are open consultations for items being considered by the MSAC.

MSAC Consultation Survey - Application 1816

MSAC application 1816 Genetic testing to detect estrogen receptor 1 (ESR1) variants in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer to...

More

MSAC Consultation Survey - Application 1815

MSAC application 1815 Computed tomography (CT) of the coronary arteries to determine coronary artery calcium score. Consultation is open on applications for consideration by the...

More

MSAC Consultation Survey - Application 1814

MSAC application 1814 Bronchoscopic lung volume reduction with endobronchial valves for the treatment of severe emphysema. Consultation is open on applications for consideration by the...

More

MSAC Consultation Survey - Application 1813

MSAC application 1813 Detection of measurable residual disease in patients with acute myeloid leukaemia. Consultation is open on applications for consideration by the Medical Services...

More

MSAC Consultation Survey - Application 1817

MSAC application 1817 Xeomin (incobotulinumtoxinA) injection codes for lower limb spasticity following an acute event. Consultation is open on applications for consideration by the...

More

MSAC Consultation Survey - Application 1790

MSAC application 1790 POLE genotyping for the molecular classification of endometrial cancer. Consultation is open on applications for consideration by the Medical Services Advisory...

More

MSAC Consultation Survey - Application 1796

MSAC application 1796 ADAMTS13 testing for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Consultation is open on applications for consideration by the Medical Services...

More

MSAC Consultation Survey - Application 1804

MSAC application 1804 - Genetic testing to detect RET variants in patients with medullary thyroid cancer to determine eligibility for PBS subsidised selpercatinib treatment. ...

More

MSAC Consultation Survey - Application 1805

MSAC application 1805 - Concizumab for routine prophylaxis to prevent bleeding in patients with haemophilia B. Consultation is open on applications for consideration by the Medical...

More
Show more

MSAC Updates

Subscribe to MSAC email bulletins on the MSAC meeting agendas and consultations, and important updates.

Sign up